nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—PDE4D—prostate cancer	0.145	0.398	CbGaD
Theophylline—CYP1B1—prostate cancer	0.0899	0.248	CbGaD
Theophylline—CYP2E1—prostate cancer	0.0492	0.136	CbGaD
Theophylline—CYP1A1—prostate cancer	0.0486	0.134	CbGaD
Theophylline—CYP1B1—Flutamide—prostate cancer	0.0462	0.117	CbGbCtD
Theophylline—CYP1B1—Estrone—prostate cancer	0.0334	0.0846	CbGbCtD
Theophylline—CYP3A4—prostate cancer	0.031	0.0854	CbGaD
Theophylline—CYP1A1—Flutamide—prostate cancer	0.0203	0.0514	CbGbCtD
Theophylline—CYP1B1—Mitoxantrone—prostate cancer	0.0199	0.0503	CbGbCtD
Theophylline—CYP1B1—Estradiol—prostate cancer	0.0192	0.0486	CbGbCtD
Theophylline—CYP1A1—Estrone—prostate cancer	0.0146	0.0371	CbGbCtD
Theophylline—CYP2C8—Nilutamide—prostate cancer	0.0141	0.0358	CbGbCtD
Theophylline—CYP2C8—Abiraterone—prostate cancer	0.0117	0.0296	CbGbCtD
Theophylline—CYP1B1—Docetaxel—prostate cancer	0.0115	0.029	CbGbCtD
Theophylline—CYP2E1—Estrone—prostate cancer	0.0113	0.0287	CbGbCtD
Theophylline—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0109	0.0276	CbGbCtD
Theophylline—SLC22A7—Docetaxel—prostate cancer	0.0104	0.0263	CbGbCtD
Theophylline—CYP2C9—Bicalutamide—prostate cancer	0.00984	0.0249	CbGbCtD
Theophylline—CYP2C9—Nilutamide—prostate cancer	0.00984	0.0249	CbGbCtD
Theophylline—CYP1A2—Flutamide—prostate cancer	0.00905	0.0229	CbGbCtD
Theophylline—CYP2D6—Bicalutamide—prostate cancer	0.009	0.0228	CbGbCtD
Theophylline—CYP2C8—Cabazitaxel—prostate cancer	0.00865	0.0219	CbGbCtD
Theophylline—CYP1B1—Doxorubicin—prostate cancer	0.00854	0.0216	CbGbCtD
Theophylline—CYP1A1—Estradiol—prostate cancer	0.00841	0.0213	CbGbCtD
Theophylline—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00753	0.0191	CbGbCtD
Theophylline—CYP2D6—Abiraterone—prostate cancer	0.00746	0.0189	CbGbCtD
Theophylline—CYP2E1—Mitoxantrone—prostate cancer	0.00673	0.0171	CbGbCtD
Theophylline—CYP1A2—Estrone—prostate cancer	0.00654	0.0166	CbGbCtD
Theophylline—CYP2C9—Estrone—prostate cancer	0.0059	0.0149	CbGbCtD
Theophylline—CYP3A4—Bicalutamide—prostate cancer	0.00572	0.0145	CbGbCtD
Theophylline—CYP3A4—Estramustine—prostate cancer	0.00532	0.0135	CbGbCtD
Theophylline—CYP2C8—Estradiol—prostate cancer	0.00485	0.0123	CbGbCtD
Theophylline—CYP3A4—Abiraterone—prostate cancer	0.00474	0.012	CbGbCtD
Theophylline—CYP3A4—Flutamide—prostate cancer	0.00474	0.012	CbGbCtD
Theophylline—CYP2C9—Capecitabine—prostate cancer	0.00447	0.0113	CbGbCtD
Theophylline—CYP1A2—Conjugated Estrogens—prostate cancer	0.00428	0.0108	CbGbCtD
Theophylline—CYP2E1—Etoposide—prostate cancer	0.00424	0.0108	CbGbCtD
Theophylline—PDE5A—penis—prostate cancer	0.00401	0.0875	CbGeAlD
Theophylline—PDE3A—penis—prostate cancer	0.0039	0.0851	CbGeAlD
Theophylline—CYP1A2—Estradiol—prostate cancer	0.00376	0.00953	CbGbCtD
Theophylline—CYP3A4—Cabazitaxel—prostate cancer	0.00351	0.00889	CbGbCtD
Theophylline—CYP3A4—Estrone—prostate cancer	0.00343	0.00869	CbGbCtD
Theophylline—CYP2C9—Estradiol—prostate cancer	0.00339	0.00858	CbGbCtD
Theophylline—CYP2C8—Etoposide—prostate cancer	0.00317	0.00803	CbGbCtD
Theophylline—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00306	0.00774	CbGbCtD
Theophylline—CYP1A2—Etoposide—prostate cancer	0.00245	0.00622	CbGbCtD
Theophylline—CYP3A4—Conjugated Estrogens—prostate cancer	0.00224	0.00568	CbGbCtD
Theophylline—CYP3A4—Mitoxantrone—prostate cancer	0.00204	0.00517	CbGbCtD
Theophylline—CYP3A4—Estradiol—prostate cancer	0.00197	0.00499	CbGbCtD
Theophylline—CYP3A4—Prednisone—prostate cancer	0.00169	0.00429	CbGbCtD
Theophylline—PDE3B—prostate gland—prostate cancer	0.00153	0.0333	CbGeAlD
Theophylline—CYP2D6—Doxorubicin—prostate cancer	0.00138	0.0035	CbGbCtD
Theophylline—CYP3A4—Etoposide—prostate cancer	0.00129	0.00326	CbGbCtD
Theophylline—PDE4D—prostate gland—prostate cancer	0.00127	0.0278	CbGeAlD
Theophylline—ADORA2B—prostate gland—prostate cancer	0.00127	0.0276	CbGeAlD
Theophylline—CYP3A4—Docetaxel—prostate cancer	0.00118	0.00298	CbGbCtD
Theophylline—ADA—prostate gland—prostate cancer	0.00116	0.0252	CbGeAlD
Theophylline—CYP1A2—urine—prostate cancer	0.00115	0.0251	CbGeAlD
Theophylline—PDE4A—prostate gland—prostate cancer	0.00113	0.0246	CbGeAlD
Theophylline—CYP2C9—urine—prostate cancer	0.00109	0.0238	CbGeAlD
Theophylline—CYP2E1—urine—prostate cancer	0.00103	0.0226	CbGeAlD
Theophylline—PDE5A—prostate gland—prostate cancer	0.000959	0.0209	CbGeAlD
Theophylline—PDE3A—prostate gland—prostate cancer	0.000933	0.0203	CbGeAlD
Theophylline—HDAC2—prostate gland—prostate cancer	0.000898	0.0196	CbGeAlD
Theophylline—CYP3A4—Doxorubicin—prostate cancer	0.000877	0.00222	CbGbCtD
Theophylline—ADORA2B—urethra—prostate cancer	0.000847	0.0185	CbGeAlD
Theophylline—CYP3A4—urine—prostate cancer	0.000833	0.0182	CbGeAlD
Theophylline—Caffeine—PRKDC—prostate cancer	0.000822	0.2	CrCbGaD
Theophylline—CYP2D6—urine—prostate cancer	0.000819	0.0179	CbGeAlD
Theophylline—ADA—renal system—prostate cancer	0.000789	0.0172	CbGeAlD
Theophylline—PDE3B—bone marrow—prostate cancer	0.000787	0.0172	CbGeAlD
Theophylline—HDAC2—Teniposide—Etoposide—prostate cancer	0.000758	0.738	CbGdCrCtD
Theophylline—SLC22A7—renal system—prostate cancer	0.000711	0.0155	CbGeAlD
Theophylline—PDE5A—epithelium—prostate cancer	0.000705	0.0154	CbGeAlD
Theophylline—PDE3B—testis—prostate cancer	0.000673	0.0147	CbGeAlD
Theophylline—PDE4B—prostate gland—prostate cancer	0.000672	0.0147	CbGeAlD
Theophylline—HDAC2—epithelium—prostate cancer	0.00066	0.0144	CbGeAlD
Theophylline—PDE5A—renal system—prostate cancer	0.000653	0.0142	CbGeAlD
Theophylline—PDE5A—urethra—prostate cancer	0.000642	0.014	CbGeAlD
Theophylline—ADORA1—renal system—prostate cancer	0.00062	0.0135	CbGeAlD
Theophylline—HDAC2—renal system—prostate cancer	0.000612	0.0133	CbGeAlD
Theophylline—ADORA1—urethra—prostate cancer	0.000609	0.0133	CbGeAlD
Theophylline—ADA—bone marrow—prostate cancer	0.000596	0.013	CbGeAlD
Theophylline—CYP1B1—prostate gland—prostate cancer	0.000576	0.0126	CbGeAlD
Theophylline—PDE4D—testis—prostate cancer	0.000561	0.0122	CbGeAlD
Theophylline—ADORA2B—testis—prostate cancer	0.000557	0.0122	CbGeAlD
Theophylline—ADA—testis—prostate cancer	0.00051	0.0111	CbGeAlD
Theophylline—PDE4A—testis—prostate cancer	0.000497	0.0108	CbGeAlD
Theophylline—PDE3B—lymph node—prostate cancer	0.000488	0.0106	CbGeAlD
Theophylline—Caffeine—ATM—prostate cancer	0.000472	0.115	CrCbGaD
Theophylline—ADORA2A—testis—prostate cancer	0.000464	0.0101	CbGeAlD
Theophylline—HDAC2—bone marrow—prostate cancer	0.000463	0.0101	CbGeAlD
Theophylline—SLC22A7—testis—prostate cancer	0.00046	0.01	CbGeAlD
Theophylline—PDE4B—urethra—prostate cancer	0.00045	0.00981	CbGeAlD
Theophylline—Caffeine—PIK3CD—prostate cancer	0.000432	0.105	CrCbGaD
Theophylline—Caffeine—PIK3CB—prostate cancer	0.000432	0.105	CrCbGaD
Theophylline—PDE5A—testis—prostate cancer	0.000422	0.00921	CbGeAlD
Theophylline—PDE3A—testis—prostate cancer	0.000411	0.00896	CbGeAlD
Theophylline—PDE4D—lymph node—prostate cancer	0.000407	0.00887	CbGeAlD
Theophylline—ADORA1—testis—prostate cancer	0.0004	0.00873	CbGeAlD
Theophylline—HDAC2—testis—prostate cancer	0.000396	0.00862	CbGeAlD
Theophylline—CYP1B1—renal system—prostate cancer	0.000393	0.00856	CbGeAlD
Theophylline—CYP2E1—prostate gland—prostate cancer	0.000371	0.0081	CbGeAlD
Theophylline—ADA—lymph node—prostate cancer	0.000369	0.00806	CbGeAlD
Theophylline—Oxtriphylline—PDE4D—prostate cancer	0.000367	0.0894	CrCbGaD
Theophylline—PDE4A—lymph node—prostate cancer	0.00036	0.00785	CbGeAlD
Theophylline—PDE4B—bone marrow—prostate cancer	0.000346	0.00755	CbGeAlD
Theophylline—Caffeine—PIK3CA—prostate cancer	0.000334	0.0813	CrCbGaD
Theophylline—CYP2E1—seminal vesicle—prostate cancer	0.000314	0.00685	CbGeAlD
Theophylline—Dyphylline—PDE4D—prostate cancer	0.000312	0.076	CrCbGaD
Theophylline—PDE5A—lymph node—prostate cancer	0.000306	0.00668	CbGeAlD
Theophylline—CYP2C8—renal system—prostate cancer	0.000301	0.00656	CbGeAlD
Theophylline—CYP1A1—epithelium—prostate cancer	0.000299	0.00653	CbGeAlD
Theophylline—PDE3A—lymph node—prostate cancer	0.000298	0.00649	CbGeAlD
Theophylline—PDE4B—testis—prostate cancer	0.000296	0.00646	CbGeAlD
Theophylline—ADORA1—lymph node—prostate cancer	0.00029	0.00633	CbGeAlD
Theophylline—HDAC2—lymph node—prostate cancer	0.000287	0.00625	CbGeAlD
Theophylline—CYP1A2—renal system—prostate cancer	0.000281	0.00614	CbGeAlD
Theophylline—CYP1A1—renal system—prostate cancer	0.000278	0.00605	CbGeAlD
Theophylline—CYP1A1—urethra—prostate cancer	0.000273	0.00595	CbGeAlD
Theophylline—HDAC2—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000269	0.262	CbGdCrCtD
Theophylline—CYP1B1—testis—prostate cancer	0.000254	0.00553	CbGeAlD
Theophylline—CYP2E1—renal system—prostate cancer	0.000253	0.00552	CbGeAlD
Theophylline—CYP2E1—urethra—prostate cancer	0.000249	0.00542	CbGeAlD
Theophylline—Aminophylline—CYP2E1—prostate cancer	0.000218	0.053	CrCbGaD
Theophylline—PDE4B—lymph node—prostate cancer	0.000215	0.00468	CbGeAlD
Theophylline—CYP3A4—renal system—prostate cancer	0.000204	0.00444	CbGeAlD
Theophylline—CYP2D6—renal system—prostate cancer	0.0002	0.00437	CbGeAlD
Theophylline—CYP2C8—testis—prostate cancer	0.000194	0.00424	CbGeAlD
Theophylline—CYP1B1—lymph node—prostate cancer	0.000184	0.00401	CbGeAlD
Theophylline—CYP2E1—testis—prostate cancer	0.000164	0.00357	CbGeAlD
Theophylline—Theobromine—CYP2E1—prostate cancer	0.000145	0.0352	CrCbGaD
Theophylline—Aminophylline—CYP3A4—prostate cancer	0.000137	0.0334	CrCbGaD
Theophylline—Caffeine—CYP1B1—prostate cancer	0.000136	0.0331	CrCbGaD
Theophylline—CYP1A1—lymph node—prostate cancer	0.00013	0.00284	CbGeAlD
Theophylline—CYP2D6—testis—prostate cancer	0.00013	0.00283	CbGeAlD
Theophylline—Caffeine—CYP3A5—prostate cancer	0.000108	0.0263	CrCbGaD
Theophylline—Dizziness—Ethinyl Estradiol—prostate cancer	9.58e-05	0.00112	CcSEcCtD
Theophylline—Flushing—Etoposide—prostate cancer	9.57e-05	0.00112	CcSEcCtD
Theophylline—Urticaria—Goserelin—prostate cancer	9.48e-05	0.00111	CcSEcCtD
Theophylline—Anaphylactic shock—Estradiol—prostate cancer	9.46e-05	0.00111	CcSEcCtD
Theophylline—Body temperature increased—Goserelin—prostate cancer	9.43e-05	0.0011	CcSEcCtD
Theophylline—Abdominal pain—Goserelin—prostate cancer	9.43e-05	0.0011	CcSEcCtD
Theophylline—Infection—Estradiol—prostate cancer	9.39e-05	0.0011	CcSEcCtD
Theophylline—Urticaria—Conjugated Estrogens—prostate cancer	9.39e-05	0.0011	CcSEcCtD
Theophylline—Hyperglycaemia—Capecitabine—prostate cancer	9.35e-05	0.0011	CcSEcCtD
Theophylline—Convulsion—Mitoxantrone—prostate cancer	9.35e-05	0.0011	CcSEcCtD
Theophylline—Body temperature increased—Conjugated Estrogens—prostate cancer	9.34e-05	0.00109	CcSEcCtD
Theophylline—Abdominal pain—Conjugated Estrogens—prostate cancer	9.34e-05	0.00109	CcSEcCtD
Theophylline—Shock—Estradiol—prostate cancer	9.3e-05	0.00109	CcSEcCtD
Theophylline—Nervous system disorder—Estradiol—prostate cancer	9.27e-05	0.00109	CcSEcCtD
Theophylline—Tachycardia—Estradiol—prostate cancer	9.23e-05	0.00108	CcSEcCtD
Theophylline—Vomiting—Ethinyl Estradiol—prostate cancer	9.22e-05	0.00108	CcSEcCtD
Theophylline—Anxiety—Mitoxantrone—prostate cancer	9.16e-05	0.00107	CcSEcCtD
Theophylline—Rash—Ethinyl Estradiol—prostate cancer	9.14e-05	0.00107	CcSEcCtD
Theophylline—Dermatitis—Ethinyl Estradiol—prostate cancer	9.13e-05	0.00107	CcSEcCtD
Theophylline—Alopecia—Etoposide—prostate cancer	9.12e-05	0.00107	CcSEcCtD
Theophylline—Headache—Ethinyl Estradiol—prostate cancer	9.08e-05	0.00106	CcSEcCtD
Theophylline—Phlebitis—Doxorubicin—prostate cancer	8.98e-05	0.00105	CcSEcCtD
Theophylline—Dermatitis exfoliative—Epirubicin—prostate cancer	8.86e-05	0.00104	CcSEcCtD
Theophylline—Haematuria—Capecitabine—prostate cancer	8.82e-05	0.00103	CcSEcCtD
Theophylline—Anaphylactic shock—Mitoxantrone—prostate cancer	8.81e-05	0.00103	CcSEcCtD
Theophylline—Hypersensitivity—Goserelin—prostate cancer	8.79e-05	0.00103	CcSEcCtD
Theophylline—Infection—Mitoxantrone—prostate cancer	8.75e-05	0.00103	CcSEcCtD
Theophylline—Hypersensitivity—Conjugated Estrogens—prostate cancer	8.71e-05	0.00102	CcSEcCtD
Theophylline—Shock—Mitoxantrone—prostate cancer	8.67e-05	0.00102	CcSEcCtD
Theophylline—Anaphylactoid reaction—Epirubicin—prostate cancer	8.64e-05	0.00101	CcSEcCtD
Theophylline—Nausea—Ethinyl Estradiol—prostate cancer	8.61e-05	0.00101	CcSEcCtD
Theophylline—Tachycardia—Mitoxantrone—prostate cancer	8.6e-05	0.00101	CcSEcCtD
Theophylline—Insomnia—Estradiol—prostate cancer	8.55e-05	0.001	CcSEcCtD
Theophylline—Pruritus—Goserelin—prostate cancer	8.44e-05	0.000988	CcSEcCtD
Theophylline—Anorexia—Mitoxantrone—prostate cancer	8.4e-05	0.000984	CcSEcCtD
Theophylline—Pruritus—Conjugated Estrogens—prostate cancer	8.36e-05	0.000979	CcSEcCtD
Theophylline—Hyperglycaemia—Prednisone—prostate cancer	8.33e-05	0.000976	CcSEcCtD
Theophylline—Hypotension—Mitoxantrone—prostate cancer	8.23e-05	0.000964	CcSEcCtD
Theophylline—Decreased appetite—Estradiol—prostate cancer	8.22e-05	0.000963	CcSEcCtD
Theophylline—Dermatitis exfoliative—Doxorubicin—prostate cancer	8.2e-05	0.00096	CcSEcCtD
Theophylline—Diarrhoea—Goserelin—prostate cancer	8.16e-05	0.000956	CcSEcCtD
Theophylline—Diarrhoea—Conjugated Estrogens—prostate cancer	8.08e-05	0.000947	CcSEcCtD
Theophylline—Anaphylactoid reaction—Doxorubicin—prostate cancer	7.99e-05	0.000936	CcSEcCtD
Theophylline—Flushing—Docetaxel—prostate cancer	7.96e-05	0.000932	CcSEcCtD
Theophylline—Dizziness—Goserelin—prostate cancer	7.89e-05	0.000924	CcSEcCtD
Theophylline—Dizziness—Conjugated Estrogens—prostate cancer	7.81e-05	0.000915	CcSEcCtD
Theophylline—Convulsion—Etoposide—prostate cancer	7.78e-05	0.000911	CcSEcCtD
Theophylline—Gastrointestinal pain—Estradiol—prostate cancer	7.73e-05	0.000906	CcSEcCtD
Theophylline—Flushing—Capecitabine—prostate cancer	7.7e-05	0.000902	CcSEcCtD
Theophylline—Decreased appetite—Mitoxantrone—prostate cancer	7.66e-05	0.000897	CcSEcCtD
Theophylline—Arrhythmia—Docetaxel—prostate cancer	7.66e-05	0.000897	CcSEcCtD
Theophylline—Abdominal pain upper—Epirubicin—prostate cancer	7.63e-05	0.000894	CcSEcCtD
Theophylline—Hypokalaemia—Epirubicin—prostate cancer	7.61e-05	0.000891	CcSEcCtD
Theophylline—Vomiting—Goserelin—prostate cancer	7.58e-05	0.000888	CcSEcCtD
Theophylline—Alopecia—Docetaxel—prostate cancer	7.58e-05	0.000887	CcSEcCtD
Theophylline—Rash—Goserelin—prostate cancer	7.52e-05	0.000881	CcSEcCtD
Theophylline—Dermatitis—Goserelin—prostate cancer	7.51e-05	0.00088	CcSEcCtD
Theophylline—Vomiting—Conjugated Estrogens—prostate cancer	7.51e-05	0.00088	CcSEcCtD
Theophylline—Urticaria—Estradiol—prostate cancer	7.51e-05	0.00088	CcSEcCtD
Theophylline—Abdominal pain—Estradiol—prostate cancer	7.48e-05	0.000876	CcSEcCtD
Theophylline—Body temperature increased—Estradiol—prostate cancer	7.48e-05	0.000876	CcSEcCtD
Theophylline—Headache—Goserelin—prostate cancer	7.47e-05	0.000875	CcSEcCtD
Theophylline—Rash—Conjugated Estrogens—prostate cancer	7.45e-05	0.000873	CcSEcCtD
Theophylline—Dermatitis—Conjugated Estrogens—prostate cancer	7.44e-05	0.000872	CcSEcCtD
Theophylline—Caffeine—CYP2E1—prostate cancer	7.44e-05	0.0181	CrCbGaD
Theophylline—Arrhythmia—Capecitabine—prostate cancer	7.41e-05	0.000868	CcSEcCtD
Theophylline—Headache—Conjugated Estrogens—prostate cancer	7.4e-05	0.000867	CcSEcCtD
Theophylline—Caffeine—CYP1A1—prostate cancer	7.34e-05	0.0179	CrCbGaD
Theophylline—Alopecia—Capecitabine—prostate cancer	7.33e-05	0.000859	CcSEcCtD
Theophylline—Anaphylactic shock—Etoposide—prostate cancer	7.33e-05	0.000858	CcSEcCtD
Theophylline—Infection—Etoposide—prostate cancer	7.28e-05	0.000853	CcSEcCtD
Theophylline—Gastrointestinal pain—Mitoxantrone—prostate cancer	7.2e-05	0.000844	CcSEcCtD
Theophylline—Tachycardia—Etoposide—prostate cancer	7.15e-05	0.000838	CcSEcCtD
Theophylline—Nausea—Goserelin—prostate cancer	7.09e-05	0.00083	CcSEcCtD
Theophylline—Abdominal pain upper—Doxorubicin—prostate cancer	7.06e-05	0.000827	CcSEcCtD
Theophylline—Hypokalaemia—Doxorubicin—prostate cancer	7.04e-05	0.000824	CcSEcCtD
Theophylline—Nausea—Conjugated Estrogens—prostate cancer	7.02e-05	0.000822	CcSEcCtD
Theophylline—Urticaria—Mitoxantrone—prostate cancer	7e-05	0.00082	CcSEcCtD
Theophylline—Anorexia—Etoposide—prostate cancer	6.99e-05	0.000818	CcSEcCtD
Theophylline—Hypersensitivity—Estradiol—prostate cancer	6.97e-05	0.000816	CcSEcCtD
Theophylline—Abdominal pain—Mitoxantrone—prostate cancer	6.97e-05	0.000816	CcSEcCtD
Theophylline—Body temperature increased—Mitoxantrone—prostate cancer	6.97e-05	0.000816	CcSEcCtD
Theophylline—Flushing—Prednisone—prostate cancer	6.86e-05	0.000804	CcSEcCtD
Theophylline—Hypotension—Etoposide—prostate cancer	6.85e-05	0.000802	CcSEcCtD
Theophylline—Tremor—Capecitabine—prostate cancer	6.77e-05	0.000793	CcSEcCtD
Theophylline—Pruritus—Estradiol—prostate cancer	6.69e-05	0.000784	CcSEcCtD
Theophylline—Arrhythmia—Prednisone—prostate cancer	6.6e-05	0.000774	CcSEcCtD
Theophylline—Palpitations—Docetaxel—prostate cancer	6.6e-05	0.000772	CcSEcCtD
Theophylline—Alopecia—Prednisone—prostate cancer	6.53e-05	0.000765	CcSEcCtD
Theophylline—Hyperglycaemia—Epirubicin—prostate cancer	6.52e-05	0.000763	CcSEcCtD
Theophylline—Hypersensitivity—Mitoxantrone—prostate cancer	6.49e-05	0.00076	CcSEcCtD
Theophylline—Diarrhoea—Estradiol—prostate cancer	6.47e-05	0.000758	CcSEcCtD
Theophylline—Convulsion—Docetaxel—prostate cancer	6.47e-05	0.000757	CcSEcCtD
Theophylline—Palpitations—Capecitabine—prostate cancer	6.39e-05	0.000748	CcSEcCtD
Theophylline—Decreased appetite—Etoposide—prostate cancer	6.37e-05	0.000746	CcSEcCtD
Theophylline—Dizziness—Estradiol—prostate cancer	6.25e-05	0.000732	CcSEcCtD
Theophylline—Haematuria—Epirubicin—prostate cancer	6.14e-05	0.000719	CcSEcCtD
Theophylline—Anxiety—Capecitabine—prostate cancer	6.13e-05	0.000718	CcSEcCtD
Theophylline—Anaphylactic shock—Docetaxel—prostate cancer	6.09e-05	0.000713	CcSEcCtD
Theophylline—Infection—Docetaxel—prostate cancer	6.05e-05	0.000709	CcSEcCtD
Theophylline—Hyperglycaemia—Doxorubicin—prostate cancer	6.03e-05	0.000706	CcSEcCtD
Theophylline—Diarrhoea—Mitoxantrone—prostate cancer	6.03e-05	0.000706	CcSEcCtD
Theophylline—Vomiting—Estradiol—prostate cancer	6.01e-05	0.000704	CcSEcCtD
Theophylline—Gastrointestinal pain—Etoposide—prostate cancer	5.99e-05	0.000702	CcSEcCtD
Theophylline—Shock—Docetaxel—prostate cancer	5.99e-05	0.000702	CcSEcCtD
Theophylline—Nervous system disorder—Docetaxel—prostate cancer	5.97e-05	0.0007	CcSEcCtD
Theophylline—Rash—Estradiol—prostate cancer	5.96e-05	0.000698	CcSEcCtD
Theophylline—Dermatitis—Estradiol—prostate cancer	5.96e-05	0.000698	CcSEcCtD
Theophylline—Tachycardia—Docetaxel—prostate cancer	5.94e-05	0.000696	CcSEcCtD
Theophylline—Headache—Estradiol—prostate cancer	5.92e-05	0.000694	CcSEcCtD
Theophylline—Agitation—Prednisone—prostate cancer	5.91e-05	0.000693	CcSEcCtD
Theophylline—Infection—Capecitabine—prostate cancer	5.86e-05	0.000686	CcSEcCtD
Theophylline—Urticaria—Etoposide—prostate cancer	5.82e-05	0.000682	CcSEcCtD
Theophylline—Anorexia—Docetaxel—prostate cancer	5.81e-05	0.00068	CcSEcCtD
Theophylline—Shock—Capecitabine—prostate cancer	5.8e-05	0.00068	CcSEcCtD
Theophylline—Abdominal pain—Etoposide—prostate cancer	5.79e-05	0.000679	CcSEcCtD
Theophylline—Body temperature increased—Etoposide—prostate cancer	5.79e-05	0.000679	CcSEcCtD
Theophylline—Nervous system disorder—Capecitabine—prostate cancer	5.78e-05	0.000677	CcSEcCtD
Theophylline—Tachycardia—Capecitabine—prostate cancer	5.76e-05	0.000674	CcSEcCtD
Theophylline—Hypotension—Docetaxel—prostate cancer	5.69e-05	0.000667	CcSEcCtD
Theophylline—Haematuria—Doxorubicin—prostate cancer	5.68e-05	0.000666	CcSEcCtD
Theophylline—Anorexia—Capecitabine—prostate cancer	5.62e-05	0.000658	CcSEcCtD
Theophylline—Nausea—Estradiol—prostate cancer	5.62e-05	0.000658	CcSEcCtD
Theophylline—Vomiting—Mitoxantrone—prostate cancer	5.6e-05	0.000656	CcSEcCtD
Theophylline—Convulsion—Prednisone—prostate cancer	5.58e-05	0.000653	CcSEcCtD
Theophylline—Rash—Mitoxantrone—prostate cancer	5.56e-05	0.000651	CcSEcCtD
Theophylline—Dermatitis—Mitoxantrone—prostate cancer	5.55e-05	0.00065	CcSEcCtD
Theophylline—Headache—Mitoxantrone—prostate cancer	5.52e-05	0.000647	CcSEcCtD
Theophylline—Hypotension—Capecitabine—prostate cancer	5.51e-05	0.000645	CcSEcCtD
Theophylline—Insomnia—Docetaxel—prostate cancer	5.51e-05	0.000645	CcSEcCtD
Theophylline—Anxiety—Prednisone—prostate cancer	5.46e-05	0.00064	CcSEcCtD
Theophylline—Hypersensitivity—Etoposide—prostate cancer	5.4e-05	0.000632	CcSEcCtD
Theophylline—Flushing—Epirubicin—prostate cancer	5.37e-05	0.000629	CcSEcCtD
Theophylline—Insomnia—Capecitabine—prostate cancer	5.33e-05	0.000625	CcSEcCtD
Theophylline—Decreased appetite—Docetaxel—prostate cancer	5.29e-05	0.00062	CcSEcCtD
Theophylline—Anaphylactic shock—Prednisone—prostate cancer	5.25e-05	0.000615	CcSEcCtD
Theophylline—Nausea—Mitoxantrone—prostate cancer	5.23e-05	0.000613	CcSEcCtD
Theophylline—Infection—Prednisone—prostate cancer	5.22e-05	0.000611	CcSEcCtD
Theophylline—Pruritus—Etoposide—prostate cancer	5.19e-05	0.000607	CcSEcCtD
Theophylline—Shock—Prednisone—prostate cancer	5.17e-05	0.000605	CcSEcCtD
Theophylline—Arrhythmia—Epirubicin—prostate cancer	5.17e-05	0.000605	CcSEcCtD
Theophylline—Nervous system disorder—Prednisone—prostate cancer	5.15e-05	0.000603	CcSEcCtD
Theophylline—Tachycardia—Prednisone—prostate cancer	5.13e-05	0.0006	CcSEcCtD
Theophylline—Decreased appetite—Capecitabine—prostate cancer	5.13e-05	0.0006	CcSEcCtD
Theophylline—Alopecia—Epirubicin—prostate cancer	5.11e-05	0.000598	CcSEcCtD
Theophylline—Diarrhoea—Etoposide—prostate cancer	5.01e-05	0.000587	CcSEcCtD
Theophylline—Anorexia—Prednisone—prostate cancer	5.01e-05	0.000586	CcSEcCtD
Theophylline—Gastrointestinal pain—Docetaxel—prostate cancer	4.98e-05	0.000583	CcSEcCtD
Theophylline—Flushing—Doxorubicin—prostate cancer	4.97e-05	0.000582	CcSEcCtD
Theophylline—Tension—Epirubicin—prostate cancer	4.94e-05	0.000579	CcSEcCtD
Theophylline—Nervousness—Epirubicin—prostate cancer	4.89e-05	0.000573	CcSEcCtD
Theophylline—Dizziness—Etoposide—prostate cancer	4.85e-05	0.000568	CcSEcCtD
Theophylline—Gastrointestinal pain—Capecitabine—prostate cancer	4.82e-05	0.000565	CcSEcCtD
Theophylline—Abdominal pain—Docetaxel—prostate cancer	4.81e-05	0.000564	CcSEcCtD
Theophylline—Body temperature increased—Docetaxel—prostate cancer	4.81e-05	0.000564	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—prostate cancer	4.78e-05	0.00056	CcSEcCtD
Theophylline—Insomnia—Prednisone—prostate cancer	4.75e-05	0.000556	CcSEcCtD
Theophylline—Alopecia—Doxorubicin—prostate cancer	4.73e-05	0.000554	CcSEcCtD
Theophylline—Caffeine—CYP3A4—prostate cancer	4.69e-05	0.0114	CrCbGaD
Theophylline—Urticaria—Capecitabine—prostate cancer	4.68e-05	0.000549	CcSEcCtD
Theophylline—Body temperature increased—Capecitabine—prostate cancer	4.66e-05	0.000546	CcSEcCtD
Theophylline—Abdominal pain—Capecitabine—prostate cancer	4.66e-05	0.000546	CcSEcCtD
Theophylline—Vomiting—Etoposide—prostate cancer	4.66e-05	0.000546	CcSEcCtD
Theophylline—Agitation—Epirubicin—prostate cancer	4.63e-05	0.000542	CcSEcCtD
Theophylline—Rash—Etoposide—prostate cancer	4.62e-05	0.000541	CcSEcCtD
Theophylline—Dermatitis—Etoposide—prostate cancer	4.62e-05	0.000541	CcSEcCtD
Theophylline—Headache—Etoposide—prostate cancer	4.59e-05	0.000538	CcSEcCtD
Theophylline—Tension—Doxorubicin—prostate cancer	4.57e-05	0.000535	CcSEcCtD
Theophylline—Decreased appetite—Prednisone—prostate cancer	4.57e-05	0.000535	CcSEcCtD
Theophylline—Nervousness—Doxorubicin—prostate cancer	4.52e-05	0.00053	CcSEcCtD
Theophylline—Hypersensitivity—Docetaxel—prostate cancer	4.49e-05	0.000526	CcSEcCtD
Theophylline—Palpitations—Epirubicin—prostate cancer	4.45e-05	0.000521	CcSEcCtD
Theophylline—Convulsion—Epirubicin—prostate cancer	4.36e-05	0.000511	CcSEcCtD
Theophylline—Nausea—Etoposide—prostate cancer	4.35e-05	0.00051	CcSEcCtD
Theophylline—Hypersensitivity—Capecitabine—prostate cancer	4.34e-05	0.000509	CcSEcCtD
Theophylline—Pruritus—Docetaxel—prostate cancer	4.31e-05	0.000505	CcSEcCtD
Theophylline—Gastrointestinal pain—Prednisone—prostate cancer	4.3e-05	0.000503	CcSEcCtD
Theophylline—Agitation—Doxorubicin—prostate cancer	4.28e-05	0.000501	CcSEcCtD
Theophylline—Anxiety—Epirubicin—prostate cancer	4.27e-05	0.0005	CcSEcCtD
Theophylline—Urticaria—Prednisone—prostate cancer	4.17e-05	0.000489	CcSEcCtD
Theophylline—Pruritus—Capecitabine—prostate cancer	4.17e-05	0.000489	CcSEcCtD
Theophylline—Diarrhoea—Docetaxel—prostate cancer	4.17e-05	0.000488	CcSEcCtD
Theophylline—Body temperature increased—Prednisone—prostate cancer	4.15e-05	0.000486	CcSEcCtD
Theophylline—Abdominal pain—Prednisone—prostate cancer	4.15e-05	0.000486	CcSEcCtD
Theophylline—Palpitations—Doxorubicin—prostate cancer	4.12e-05	0.000482	CcSEcCtD
Theophylline—Anaphylactic shock—Epirubicin—prostate cancer	4.11e-05	0.000481	CcSEcCtD
Theophylline—Infection—Epirubicin—prostate cancer	4.08e-05	0.000478	CcSEcCtD
Theophylline—Shock—Epirubicin—prostate cancer	4.04e-05	0.000473	CcSEcCtD
Theophylline—Convulsion—Doxorubicin—prostate cancer	4.04e-05	0.000473	CcSEcCtD
Theophylline—Diarrhoea—Capecitabine—prostate cancer	4.03e-05	0.000473	CcSEcCtD
Theophylline—Nervous system disorder—Epirubicin—prostate cancer	4.03e-05	0.000472	CcSEcCtD
Theophylline—Dizziness—Docetaxel—prostate cancer	4.03e-05	0.000472	CcSEcCtD
Theophylline—Tachycardia—Epirubicin—prostate cancer	4.01e-05	0.00047	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—prostate cancer	3.95e-05	0.000463	CcSEcCtD
Theophylline—Anorexia—Epirubicin—prostate cancer	3.92e-05	0.000459	CcSEcCtD
Theophylline—Dizziness—Capecitabine—prostate cancer	3.9e-05	0.000457	CcSEcCtD
Theophylline—Vomiting—Docetaxel—prostate cancer	3.87e-05	0.000454	CcSEcCtD
Theophylline—Hypersensitivity—Prednisone—prostate cancer	3.87e-05	0.000453	CcSEcCtD
Theophylline—Rash—Docetaxel—prostate cancer	3.84e-05	0.00045	CcSEcCtD
Theophylline—Hypotension—Epirubicin—prostate cancer	3.84e-05	0.00045	CcSEcCtD
Theophylline—Dermatitis—Docetaxel—prostate cancer	3.84e-05	0.000449	CcSEcCtD
Theophylline—Headache—Docetaxel—prostate cancer	3.82e-05	0.000447	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—prostate cancer	3.8e-05	0.000445	CcSEcCtD
Theophylline—Infection—Doxorubicin—prostate cancer	3.78e-05	0.000442	CcSEcCtD
Theophylline—Vomiting—Capecitabine—prostate cancer	3.75e-05	0.000439	CcSEcCtD
Theophylline—Shock—Doxorubicin—prostate cancer	3.74e-05	0.000438	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—prostate cancer	3.73e-05	0.000437	CcSEcCtD
Theophylline—Rash—Capecitabine—prostate cancer	3.72e-05	0.000436	CcSEcCtD
Theophylline—Pruritus—Prednisone—prostate cancer	3.72e-05	0.000435	CcSEcCtD
Theophylline—Insomnia—Epirubicin—prostate cancer	3.72e-05	0.000435	CcSEcCtD
Theophylline—Dermatitis—Capecitabine—prostate cancer	3.71e-05	0.000435	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—prostate cancer	3.71e-05	0.000435	CcSEcCtD
Theophylline—Headache—Capecitabine—prostate cancer	3.69e-05	0.000433	CcSEcCtD
Theophylline—Anorexia—Doxorubicin—prostate cancer	3.62e-05	0.000424	CcSEcCtD
Theophylline—Nausea—Docetaxel—prostate cancer	3.62e-05	0.000424	CcSEcCtD
Theophylline—Diarrhoea—Prednisone—prostate cancer	3.59e-05	0.000421	CcSEcCtD
Theophylline—Decreased appetite—Epirubicin—prostate cancer	3.57e-05	0.000418	CcSEcCtD
Theophylline—Hypotension—Doxorubicin—prostate cancer	3.55e-05	0.000416	CcSEcCtD
Theophylline—Nausea—Capecitabine—prostate cancer	3.5e-05	0.00041	CcSEcCtD
Theophylline—Dizziness—Prednisone—prostate cancer	3.47e-05	0.000407	CcSEcCtD
Theophylline—Insomnia—Doxorubicin—prostate cancer	3.44e-05	0.000403	CcSEcCtD
Theophylline—Gastrointestinal pain—Epirubicin—prostate cancer	3.36e-05	0.000393	CcSEcCtD
Theophylline—Vomiting—Prednisone—prostate cancer	3.34e-05	0.000391	CcSEcCtD
Theophylline—Rash—Prednisone—prostate cancer	3.31e-05	0.000388	CcSEcCtD
Theophylline—Dermatitis—Prednisone—prostate cancer	3.31e-05	0.000388	CcSEcCtD
Theophylline—Decreased appetite—Doxorubicin—prostate cancer	3.3e-05	0.000387	CcSEcCtD
Theophylline—Headache—Prednisone—prostate cancer	3.29e-05	0.000385	CcSEcCtD
Theophylline—Urticaria—Epirubicin—prostate cancer	3.26e-05	0.000382	CcSEcCtD
Theophylline—Abdominal pain—Epirubicin—prostate cancer	3.25e-05	0.00038	CcSEcCtD
Theophylline—Body temperature increased—Epirubicin—prostate cancer	3.25e-05	0.00038	CcSEcCtD
Theophylline—Nausea—Prednisone—prostate cancer	3.12e-05	0.000365	CcSEcCtD
Theophylline—Gastrointestinal pain—Doxorubicin—prostate cancer	3.11e-05	0.000364	CcSEcCtD
Theophylline—Hypersensitivity—Epirubicin—prostate cancer	3.03e-05	0.000355	CcSEcCtD
Theophylline—Urticaria—Doxorubicin—prostate cancer	3.02e-05	0.000354	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—prostate cancer	3e-05	0.000352	CcSEcCtD
Theophylline—Abdominal pain—Doxorubicin—prostate cancer	3e-05	0.000352	CcSEcCtD
Theophylline—Pruritus—Epirubicin—prostate cancer	2.91e-05	0.00034	CcSEcCtD
Theophylline—Diarrhoea—Epirubicin—prostate cancer	2.81e-05	0.000329	CcSEcCtD
Theophylline—Hypersensitivity—Doxorubicin—prostate cancer	2.8e-05	0.000328	CcSEcCtD
Theophylline—Dizziness—Epirubicin—prostate cancer	2.72e-05	0.000318	CcSEcCtD
Theophylline—Pruritus—Doxorubicin—prostate cancer	2.69e-05	0.000315	CcSEcCtD
Theophylline—Vomiting—Epirubicin—prostate cancer	2.61e-05	0.000306	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—prostate cancer	2.6e-05	0.000305	CcSEcCtD
Theophylline—Rash—Epirubicin—prostate cancer	2.59e-05	0.000303	CcSEcCtD
Theophylline—Dermatitis—Epirubicin—prostate cancer	2.59e-05	0.000303	CcSEcCtD
Theophylline—Headache—Epirubicin—prostate cancer	2.57e-05	0.000301	CcSEcCtD
Theophylline—Dizziness—Doxorubicin—prostate cancer	2.51e-05	0.000294	CcSEcCtD
Theophylline—Nausea—Epirubicin—prostate cancer	2.44e-05	0.000286	CcSEcCtD
Theophylline—Vomiting—Doxorubicin—prostate cancer	2.42e-05	0.000283	CcSEcCtD
Theophylline—Rash—Doxorubicin—prostate cancer	2.4e-05	0.000281	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—prostate cancer	2.39e-05	0.00028	CcSEcCtD
Theophylline—Headache—Doxorubicin—prostate cancer	2.38e-05	0.000279	CcSEcCtD
Theophylline—Nausea—Doxorubicin—prostate cancer	2.26e-05	0.000264	CcSEcCtD
Theophylline—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.21e-06	1.14e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ERCC2—prostate cancer	1.21e-06	1.14e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KRAS—prostate cancer	1.21e-06	1.14e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—MTHFR—prostate cancer	1.21e-06	1.14e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—P4HB—prostate cancer	1.21e-06	1.14e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—prostate cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.2e-06	1.13e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KRAS—prostate cancer	1.19e-06	1.13e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—TYMS—prostate cancer	1.19e-06	1.13e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CB—prostate cancer	1.19e-06	1.12e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PIK3CA—prostate cancer	1.19e-06	1.12e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—AKT1—prostate cancer	1.19e-06	1.12e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PPARA—prostate cancer	1.18e-06	1.12e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—prostate cancer	1.18e-06	1.11e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GSTM1—prostate cancer	1.18e-06	1.11e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTGS2—prostate cancer	1.18e-06	1.11e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GGT1—prostate cancer	1.17e-06	1.11e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.17e-06	1.11e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—STAT3—prostate cancer	1.17e-06	1.1e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—AKT1—prostate cancer	1.17e-06	1.1e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—IL6—prostate cancer	1.17e-06	1.1e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GGT1—prostate cancer	1.16e-06	1.1e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NCOA2—prostate cancer	1.16e-06	1.1e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EP300—prostate cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—AKT1—prostate cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—LPL—prostate cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL6—prostate cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NCOA1—prostate cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PIK3CA—prostate cancer	1.15e-06	1.09e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—prostate cancer	1.15e-06	1.08e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NCOA1—prostate cancer	1.15e-06	1.08e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.14e-06	1.08e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.14e-06	1.08e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—MTHFR—prostate cancer	1.14e-06	1.07e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.13e-06	1.07e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SRC—prostate cancer	1.13e-06	1.06e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MED12—prostate cancer	1.12e-06	1.06e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL6—prostate cancer	1.12e-06	1.06e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.12e-06	1.06e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—prostate cancer	1.12e-06	1.05e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PPARA—prostate cancer	1.12e-06	1.05e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GNG5—prostate cancer	1.12e-06	1.05e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CAV1—prostate cancer	1.11e-06	1.05e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PIK3CA—prostate cancer	1.11e-06	1.05e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ERCC2—prostate cancer	1.11e-06	1.05e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.11e-06	1.05e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL6—prostate cancer	1.1e-06	1.04e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—RXRA—prostate cancer	1.1e-06	1.04e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—prostate cancer	1.1e-06	1.04e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PIK3CA—prostate cancer	1.1e-06	1.04e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—RXRA—prostate cancer	1.09e-06	1.03e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—STAT3—prostate cancer	1.09e-06	1.03e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MYC—prostate cancer	1.09e-06	1.03e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TGFB1—prostate cancer	1.08e-06	1.02e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.08e-06	1.02e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—AKT1—prostate cancer	1.08e-06	1.02e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NCOA3—prostate cancer	1.07e-06	1.01e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—prostate cancer	1.07e-06	1.01e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NQO1—prostate cancer	1.07e-06	1.01e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—AKT1—prostate cancer	1.07e-06	1.01e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EGFR—prostate cancer	1.06e-06	1e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—prostate cancer	1.06e-06	1e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.06e-06	1e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—COMT—prostate cancer	1.06e-06	1e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—TH—prostate cancer	1.05e-06	9.96e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTP1—prostate cancer	1.05e-06	9.95e-06	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL6—prostate cancer	1.05e-06	9.91e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—COMT—prostate cancer	1.05e-06	9.91e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CAV1—prostate cancer	1.05e-06	9.9e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.05e-06	9.89e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTP1—prostate cancer	1.04e-06	9.86e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.04e-06	9.85e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—MTHFR—prostate cancer	1.04e-06	9.84e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.04e-06	9.8e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ITPR1—prostate cancer	1.04e-06	9.79e-06	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—AKT1—prostate cancer	1.03e-06	9.77e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ITPR1—prostate cancer	1.03e-06	9.7e-06	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTEN—prostate cancer	1.03e-06	9.7e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.03e-06	9.69e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HPGDS—prostate cancer	1.02e-06	9.67e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PPARA—prostate cancer	1.02e-06	9.66e-06	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL6—prostate cancer	1.02e-06	9.64e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.02e-06	9.61e-06	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—AKT1—prostate cancer	1.02e-06	9.61e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.01e-06	9.57e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.01e-06	9.54e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MYC—prostate cancer	1.01e-06	9.53e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TGFB1—prostate cancer	1.01e-06	9.51e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—prostate cancer	1e-06	9.48e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1e-06	9.46e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ACHE—prostate cancer	9.94e-07	9.38e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTT1—prostate cancer	9.94e-07	9.38e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GGT1—prostate cancer	9.94e-07	9.38e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EGFR—prostate cancer	9.88e-07	9.32e-06	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL6—prostate cancer	9.83e-07	9.28e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP2A6—prostate cancer	9.82e-07	9.28e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—TYMS—prostate cancer	9.8e-07	9.25e-06	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—EP300—prostate cancer	9.79e-07	9.25e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NCOA1—prostate cancer	9.79e-07	9.24e-06	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL6—prostate cancer	9.71e-07	9.17e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—TYMS—prostate cancer	9.71e-07	9.17e-06	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—AKT1—prostate cancer	9.69e-07	9.14e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTM1—prostate cancer	9.68e-07	9.14e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP19A1—prostate cancer	9.65e-07	9.11e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CAV1—prostate cancer	9.61e-07	9.08e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTM1—prostate cancer	9.6e-07	9.06e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—INS—prostate cancer	9.59e-07	9.06e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKR1C3—prostate cancer	9.56e-07	9.02e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CG—prostate cancer	9.55e-07	9.02e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PRKACB—prostate cancer	9.51e-07	8.98e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—LPL—prostate cancer	9.5e-07	8.97e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—LPL—prostate cancer	9.42e-07	8.9e-06	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—AKT1—prostate cancer	9.42e-07	8.9e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP17A1—prostate cancer	9.41e-07	8.88e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CREBBP—prostate cancer	9.39e-07	8.87e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—prostate cancer	9.33e-07	8.81e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—RXRA—prostate cancer	9.31e-07	8.79e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PIK3CA—prostate cancer	9.22e-07	8.71e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.19e-07	8.67e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP1A1—prostate cancer	9.18e-07	8.67e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ERCC2—prostate cancer	9.1e-07	8.6e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP1A1—prostate cancer	9.1e-07	8.59e-06	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—AKT1—prostate cancer	9.07e-07	8.56e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.06e-07	8.55e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—INS—prostate cancer	9.04e-07	8.54e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ERCC2—prostate cancer	9.02e-07	8.52e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—COMT—prostate cancer	8.97e-07	8.47e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NCOA2—prostate cancer	8.96e-07	8.46e-06	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—AKT1—prostate cancer	8.96e-07	8.46e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTP1—prostate cancer	8.93e-07	8.43e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—prostate cancer	8.92e-07	8.42e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CD—prostate cancer	8.91e-07	8.41e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CREBBP—prostate cancer	8.86e-07	8.36e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ITPR1—prostate cancer	8.78e-07	8.29e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CG—prostate cancer	8.76e-07	8.27e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.64e-07	8.15e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CA—prostate cancer	8.57e-07	8.09e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—MTHFR—prostate cancer	8.56e-07	8.08e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SLC5A5—prostate cancer	8.55e-07	8.07e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—MTHFR—prostate cancer	8.48e-07	8.01e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—NOS3—prostate cancer	8.41e-07	7.94e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CD—prostate cancer	8.4e-07	7.93e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PPARA—prostate cancer	8.39e-07	7.93e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP2E1—prostate cancer	8.35e-07	7.89e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PPARA—prostate cancer	8.32e-07	7.86e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—TYMS—prostate cancer	8.3e-07	7.83e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—prostate cancer	8.29e-07	7.83e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—INS—prostate cancer	8.29e-07	7.83e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NQO1—prostate cancer	8.26e-07	7.8e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTM1—prostate cancer	8.2e-07	7.74e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL6—prostate cancer	8.16e-07	7.71e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—TH—prostate cancer	8.14e-07	7.69e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CREBBP—prostate cancer	8.12e-07	7.67e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—LPL—prostate cancer	8.05e-07	7.6e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—NOS3—prostate cancer	7.93e-07	7.49e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP1B1—prostate cancer	7.92e-07	7.48e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CAV1—prostate cancer	7.89e-07	7.45e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CAV1—prostate cancer	7.82e-07	7.39e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP1A1—prostate cancer	7.78e-07	7.34e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CB—prostate cancer	7.76e-07	7.33e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ERCC2—prostate cancer	7.71e-07	7.28e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CD—prostate cancer	7.7e-07	7.27e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTGS2—prostate cancer	7.69e-07	7.26e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GGT1—prostate cancer	7.67e-07	7.24e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL6—prostate cancer	7.59e-07	7.17e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NCOA1—prostate cancer	7.55e-07	7.13e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—AKT1—prostate cancer	7.53e-07	7.11e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.48e-07	7.06e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP19A1—prostate cancer	7.44e-07	7.03e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CB—prostate cancer	7.32e-07	6.91e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—NOS3—prostate cancer	7.27e-07	6.86e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTGS2—prostate cancer	7.25e-07	6.85e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—MTHFR—prostate cancer	7.25e-07	6.84e-06	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CA—prostate cancer	7.25e-07	6.84e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CG—prostate cancer	7.19e-07	6.79e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—RXRA—prostate cancer	7.19e-07	6.78e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CG—prostate cancer	7.13e-07	6.73e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PPARA—prostate cancer	7.11e-07	6.71e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—AKT1—prostate cancer	7e-07	6.61e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—COMT—prostate cancer	6.92e-07	6.54e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTP1—prostate cancer	6.89e-07	6.5e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—INS—prostate cancer	6.81e-07	6.43e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ITPR1—prostate cancer	6.78e-07	6.4e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—INS—prostate cancer	6.75e-07	6.37e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CB—prostate cancer	6.71e-07	6.34e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTEN—prostate cancer	6.71e-07	6.33e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CAV1—prostate cancer	6.69e-07	6.31e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CREBBP—prostate cancer	6.67e-07	6.29e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTGS2—prostate cancer	6.65e-07	6.28e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CREBBP—prostate cancer	6.61e-07	6.24e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—TYMS—prostate cancer	6.4e-07	6.05e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—EP300—prostate cancer	6.4e-07	6.04e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.39e-07	6.03e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTM1—prostate cancer	6.33e-07	5.98e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTEN—prostate cancer	6.32e-07	5.97e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CD—prostate cancer	6.32e-07	5.97e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CD—prostate cancer	6.27e-07	5.92e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—LPL—prostate cancer	6.21e-07	5.87e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CG—prostate cancer	6.09e-07	5.75e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—EP300—prostate cancer	6.03e-07	5.7e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP1A1—prostate cancer	6e-07	5.67e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NOS3—prostate cancer	5.97e-07	5.64e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ERCC2—prostate cancer	5.95e-07	5.62e-06	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—AKT1—prostate cancer	5.92e-07	5.59e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NOS3—prostate cancer	5.92e-07	5.59e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTEN—prostate cancer	5.8e-07	5.47e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—INS—prostate cancer	5.77e-07	5.44e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CREBBP—prostate cancer	5.65e-07	5.33e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MTHFR—prostate cancer	5.59e-07	5.28e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—EP300—prostate cancer	5.53e-07	5.22e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CB—prostate cancer	5.51e-07	5.2e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PPARA—prostate cancer	5.49e-07	5.18e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CB—prostate cancer	5.46e-07	5.16e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTGS2—prostate cancer	5.46e-07	5.15e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTGS2—prostate cancer	5.41e-07	5.11e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CD—prostate cancer	5.35e-07	5.06e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CAV1—prostate cancer	5.16e-07	4.87e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NOS3—prostate cancer	5.06e-07	4.77e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTEN—prostate cancer	4.76e-07	4.49e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CA—prostate cancer	4.73e-07	4.47e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTEN—prostate cancer	4.72e-07	4.46e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.7e-07	4.44e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CB—prostate cancer	4.67e-07	4.41e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTGS2—prostate cancer	4.62e-07	4.37e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—EP300—prostate cancer	4.54e-07	4.29e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—EP300—prostate cancer	4.5e-07	4.25e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CA—prostate cancer	4.46e-07	4.21e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—INS—prostate cancer	4.45e-07	4.2e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CREBBP—prostate cancer	4.36e-07	4.11e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.13e-07	3.9e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.09e-07	3.86e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTEN—prostate cancer	4.03e-07	3.81e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NOS3—prostate cancer	3.9e-07	3.68e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AKT1—prostate cancer	3.87e-07	3.65e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—EP300—prostate cancer	3.85e-07	3.63e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AKT1—prostate cancer	3.64e-07	3.44e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.6e-07	3.4e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS2—prostate cancer	3.57e-07	3.37e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CA—prostate cancer	3.36e-07	3.17e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AKT1—prostate cancer	3.34e-07	3.16e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.33e-07	3.14e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTEN—prostate cancer	3.11e-07	2.94e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—EP300—prostate cancer	2.97e-07	2.8e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CA—prostate cancer	2.84e-07	2.69e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKT1—prostate cancer	2.74e-07	2.59e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKT1—prostate cancer	2.72e-07	2.57e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKT1—prostate cancer	2.32e-07	2.19e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.2e-07	2.07e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKT1—prostate cancer	1.79e-07	1.69e-06	CbGpPWpGaD
